[Results] 17 weeks, 6kg, and cagrilintide was the hard part
17 weeks, 6kg, and cagrilintide was the hard part. Full detail below, and I have tried to keep the editorialising out of it. Pulling the figures out of the title: 17 weeks and 6kg. All of it is written down as it happened rather than reconstructed. Asked a question here that turned out to be based on a mechanism…
That is preclinical work and the thread is treating it as a human finding.
Same view — long-acting is the engineering achievement here, and it is why the molecule exists at all.
Yes. The combination is where the interesting effect sizes are, and the monotherapy arms read very differently.
Small fix — amylin analogue, not a GLP-1 analogue. The whole mechanism argument changes on that word.
Yes.
Adding the standing caveat — nothing here is approved standalone and research material is not for human use.
Are you comparing against a GLP-1 monotherapy result? They are not comparable.